Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RXPC > SEC Filings for RXPC > Form 8-K/A on 18-Jun-2013All Recent SEC Filings

Show all filings for RADIENT PHARMACEUTICALS CORP

Form 8-K/A for RADIENT PHARMACEUTICALS CORP


18-Jun-2013

Entry into a Material Definitive Agreement, Financial Statements a


Item 1.01 - Entry into Material Definitive Agreements

We filed a Current Report on Form 8-K on June 11, 2013 to disclose our entry into a 5-year license agreement between AMDL Diagnostics, Inc. ("ADI"), a division within our company, and Uni Pharma Co., Ltd. a Taipei Taiwan limited liability company ("UNI") that provides UNI with a 5-year exclusive license (subject to automatic renewal for an additional 5 years) to RXPC's Onko-SureŽ (formerly called DR-70 cancer blood test kits (the "Tests"), procedures, analyses, data, know how, manufacturing, manufacturing processes, components, trademarks and intellectual property.

The initial 8-K and the agreement attached as Exhibit 10.1 to the initial 8-K inaccurately disclosed that UNI only has exclusive license rights in Taiwan; however, the final agreement provides UNI with exclusive rights to the license in all of the following territories: Taiwan ROC, China PRC, Hong Kong, Malaysia, Singapore, Indonesia, Thailand, Japan, India, Turkey Australia and New Zealand. We are filing this amendment to disclose same and to file the final version of the agreement as an exhibit.



Item 9.01 Financial Statements and Exhibits

(c) Exhibits

Exhibit No.   Description

10.1          Form of Final Agreement with Uni Pharma Co., Ltd. dated June 6, 2013


  Add RXPC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RXPC - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.